Kuetting F - Search Results

1

Factors associated with reclassification of hyperplastic polyps after pathological reassessment from screening and surveillance colonoscopies.

Schramm C, Kaiser M, Drebber U, Gruenewald I, Franklin J, Kuetting F, Bowe A, Hoffmann V, Gatzke S, Toex U, Steffen HM. Schramm C, et al. Among authors: kuetting f. Int J Colorectal Dis. 2016 Feb;31(2):319-25. doi: 10.1007/s00384-015-2404-6. Epub 2015 Sep 29. Int J Colorectal Dis. 2016. PMID: 26415565

2

Patient- and procedure-related factors affecting proximal and distal detection rates for polyps and adenomas: results from 1603 screening colonoscopies.

Schramm C, Mbaya N, Franklin J, Demir M, Kuetting F, Toex U, Goeser T, Steffen HM. Schramm C, et al. Among authors: kuetting f. Int J Colorectal Dis. 2015 Dec;30(12):1715-22. doi: 10.1007/s00384-015-2360-1. Epub 2015 Aug 15. Int J Colorectal Dis. 2015. PMID: 26272199

3

Predicting ADR from PDR and individual adenoma-to-polyp-detection-rate ratio for screening and surveillance colonoscopies: A new approach to quality assessment.

Schramm C, Scheller I, Franklin J, Demir M, Kuetting F, Nierhoff D, Goeser T, Toex U, Steffen HM. Schramm C, et al. Among authors: kuetting f. United European Gastroenterol J. 2017 Aug;5(5):742-749. doi: 10.1177/2050640616675220. Epub 2016 Oct 13. United European Gastroenterol J. 2017. PMID: 28815039 Free PMC article.

4

A Novel Easy-to-Use Prediction Scheme for Upper Gastrointestinal Bleeding: Cologne-WATCH (C-WATCH) Risk Score.

Hoffmann V, Neubauer H, Heinzler J, Smarczyk A, Hellmich M, Bowe A, Kuetting F, Demir M, Pelc A, Schulte S, Toex U, Nierhoff D, Steffen HM. Hoffmann V, et al. Among authors: kuetting f. Medicine (Baltimore). 2015 Sep;94(38):e1614. doi: 10.1097/MD.0000000000001614. Medicine (Baltimore). 2015. PMID: 26402828 Free PMC article.

5

First evaluation of Neighbor of Punc E11 (NOPE) as a novel marker in human hepatocellular carcinoma.

Zweerink S, Mesghenna S, Mueck V, Schulte S, Kuetting F, Quaas A, Goeser T, Nierhoff D. Zweerink S, et al. Among authors: kuetting f. Cancer Biomark. 2021;30(1):75-83. doi: 10.3233/CBM-190819. Cancer Biomark. 2021. PMID: 32986656

6

Copy-number variation and protein expression of DOT1L in pancreatic adenocarcinoma as a potential drug target.

Loeser H, Waldschmidt D, Kuetting F, Heydt C, Zander T, Plum P, Alakus H, Buettner R, Quaas A. Loeser H, et al. Among authors: kuetting f. Mol Clin Oncol. 2017 May;6(5):639-642. doi: 10.3892/mco.2017.1194. Epub 2017 Mar 14. Mol Clin Oncol. 2017. PMID: 28529740 Free PMC article.

7

Somatic BRCA1-associated protein 1 (BAP1) loss is an early and rare event in esophageal adenocarcinoma.

Loeser H, Waldschmidt D, Kuetting F, Schallenberg S, Zander T, Bollschweiler E, Hoelscher A, Weckermann K, Plum P, Alakus H, Buettner R, Quaas A. Loeser H, et al. Among authors: kuetting f. Mol Clin Oncol. 2017 Aug;7(2):225-228. doi: 10.3892/mco.2017.1286. Epub 2017 Jun 8. Mol Clin Oncol. 2017. PMID: 28781790 Free PMC article.

8

Outcome of transarterial radioembolization in patients with hepatocellular carcinoma as a first-line interventional therapy and after a previous transarterial chemoembolization.

Wagenpfeil J, Kupczyk PA, Bruners P, Siepmann R, Guendel E, Luetkens JA, Isaak A, Meyer C, Kuetting F, Pieper CC, Attenberger UI, Kuetting D. Wagenpfeil J, et al. Among authors: kuetting f. Front Radiol. 2024 Feb 20;4:1346550. doi: 10.3389/fradi.2024.1346550. eCollection 2024. Front Radiol. 2024. PMID: 38445105 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters